IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'
IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...
Hosted on MSN1mon
IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch
IDEXX currently has a market capitalization of $35.26 billion. The company’s earnings yield of 2.79% compares favorably to the industry’s yield of -3.23%. It delivered an earnings beat of 0.9% ...